| Grading of prostatic adenocarcinoma: current state and prognostic implications J Gordetsky, J Epstein Diagnostic pathology 11, 1-8, 2016 | 396 | 2016 |
| The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, ... Archives of pathology & laboratory medicine 145 (4), 461-493, 2021 | 228 | 2021 |
| New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia K Trpkov, O Hes, SR Williamson, AJ Adeniran, A Agaimy, ... Modern Pathology 34 (7), 1392-1424, 2021 | 223 | 2021 |
| Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia K Trpkov, SR Williamson, AJ Gill, AJ Adeniran, A Agaimy, ... Modern Pathology 34 (6), 1167-1184, 2021 | 193 | 2021 |
| A magnetic resonance imaging–based prediction model for prostate biopsy risk stratification S Mehralivand, JH Shih, S Rais-Bahrami, A Oto, S Bednarova, JW Nix, ... JAMA oncology 4 (5), 678-685, 2018 | 178 | 2018 |
| High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling T Hayashi, K Fujita, S Nojima, Y Hayashi, K Nakano, Y Ishizuya, C Wang, ... Clinical Cancer Research 24 (17), 4309-4318, 2018 | 156 | 2018 |
| Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma P Ghatalia, J Gordetsky, F Kuo, E Dulaimi, KQ Cai, K Devarajan, S Bae, ... Journal for ImmunoTherapy of Cancer 7, 1-12, 2019 | 138 | 2019 |
| Gut microbiota–derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling M Matsushita, K Fujita, T Hayashi, H Kayama, D Motooka, H Hase, ... Cancer research 81 (15), 4014-4026, 2021 | 136 | 2021 |
| Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy CL Morais, JS Han, J Gordetsky, MS Nagar, AE Anderson, S Lee, ... The American journal of surgical pathology 39 (2), 169-178, 2015 | 111 | 2015 |
| Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma SP Rowe, MA Gorin, J Gordetsky, MW Ball, PM Pierorazio, T Higuchi, ... Clinical nuclear medicine 40 (4), 309-313, 2015 | 79 | 2015 |
| Factors predicting prostate cancer upgrading on magnetic resonance imaging–targeted biopsy in an active surveillance population WS Lai, JB Gordetsky, JV Thomas, JW Nix, S Rais‐Bahrami Cancer 123 (11), 1941-1948, 2017 | 78 | 2017 |
| Frozen section assessment in testicular and paratesticular lesions suspicious for malignancy: its role in preventing unnecessary orchiectomy MK Subik, J Gordetsky, JL Yao, PA di Sant'Agnese, H Miyamoto Human pathology 43 (9), 1514-1519, 2012 | 75 | 2012 |
| Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease HY Wong, Q Sheng, AB Hesterberg, S Croessmann, BL Rios, K Giri, ... Nature communications 13 (1), 6036, 2022 | 74 | 2022 |
| Quantitative iodine content threshold for discrimination of renal cell carcinomas using rapid kV-switching dual-energy CT JG Zarzour, D Milner, R Valentin, BE Jackson, J Gordetsky, J West, ... Abdominal radiology 42, 727-734, 2017 | 74 | 2017 |
| Obesity diminishes response to PD-1-based immunotherapies in renal cancer SK Boi, RM Orlandella, JT Gibson, WJ Turbitt, G Wald, L Thomas, ... Journal for immunotherapy of cancer 8 (2), e000725, 2020 | 73 | 2020 |
| Financial implications of biparametric prostate MRI KK Porter, A King, SJ Galgano, RL Sherrer, JB Gordetsky, S Rais-Bahrami Prostate cancer and prostatic diseases 23 (1), 88-93, 2020 | 72 | 2020 |
| Redefining abnormal follicle‐stimulating hormone in the male infertility population J Gordetsky, E van Wijngaarden, J O'Brien BJU international 110 (4), 568-572, 2012 | 67 | 2012 |
| Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer RL Sherrer, ZA Glaser, JB Gordetsky, JW Nix, KK Porter, S Rais-Bahrami Prostate cancer and prostatic diseases 22 (2), 331-336, 2019 | 64 | 2019 |
| miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progression BVSK Chakravarthi, DS Chandrashekar, S Agarwal, ... Molecular Cancer Research 16 (7), 1125-1137, 2018 | 63 | 2018 |
| Docetaxel combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K/AKT signaling pathway SK Singh, T Apata, JB Gordetsky, R Singh Cancers 11 (9), 1390, 2019 | 58 | 2019 |
Soroush Rais-BahramiProfessor, Departments of Urology and Radiology, University of Alabama at BirminghamPotvrđena adresa e-pošte na uabmc.edu
